0001894562-24-000004.txt : 20240119 0001894562-24-000004.hdr.sgml : 20240119 20240119161941 ACCESSION NUMBER: 0001894562-24-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240117 FILED AS OF DATE: 20240119 DATE AS OF CHANGE: 20240119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reine Allan CENTRAL INDEX KEY: 0001714023 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41536 FILM NUMBER: 24545832 MAIL ADDRESS: STREET 1: C/O PIERIS PHARMACEUTICALS, INC. STREET 2: 255 STATE STREET CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prime Medicine, Inc. CENTRAL INDEX KEY: 0001894562 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-465-0013 MAIL ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wk-form4_1705699169.xml FORM 4 X0508 4 2024-01-17 0 0001894562 Prime Medicine, Inc. PRME 0001714023 Reine Allan C/O PRIME MEDICINE, INC. 21 ERIE STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Financial Officer 0 Stock Option (right to buy) 6.80 2024-01-17 4 A 0 600000 0 A 2034-01-17 Common Stock 600000 600000 D 25% of the shares underlying this option shall vest and become exercisable on January 17, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. /s/ Marishka DeToy, attorney-in-fact 2024-01-19